| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_938a6d7a15cbc93a74abe1953eb25d47 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06034 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-10 |
| filingDate |
2008-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5dd517f10b99bdc073cb0acb50d988a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acb2ccf63d115254b7d13dc66c08fa00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_439867c18c2353d98e6fb6aba5a3f7ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_746c0597b94c4b74f40e1df2a4bb5c85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08fb4dd905c8b211a2d5e40f9ab66b88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b044871d84f3f92e40d373aacb442b5 |
| publicationDate |
2009-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20090127292-A |
| titleOfInvention |
Serine Protease Inhibitors for the Treatment of HCV Infections |
| abstract |
The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof. The compound inhibits serine proteases, in particular hepatitis C virus NS3-NS4A protease.n n n <Formula I> |
| priorityDate |
2007-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |